Skip to main content
. 2014 Aug 28;111(9):1788–1801. doi: 10.1038/bjc.2014.475

Table 2. Copy-number variation status of KRAS, MYC, CDKN2A and SMAD4 genes in 29 human pancreatic cancer cell lines with MEK162 IC50 values.

Chr name       chr12 chr8 chr9 chr18
Cytoband       p12.1 q24.21 p21.3 q21.2
Start       25259753 128818041 21958041 46814353
Stop       25259812 128818100 21958099 46814412
Cell line IC50 (μM) KRAS mut S/R KRAS MYC CDKN2A SMAD4
PANC 05.04 0.00 35G>A S 0.00 0.00 2.38 4.15
MIAPaCa 2 0.01 34G>T S 0.00 0.53 3.15 0.00
ASPC1 0.03 35G>A S 0.00 0.50 1.46 1.42
HS-766T 0.03 WT S 0.00 0.00   3.77
CAPAN-2 0.03 35G>T S 0.00 0.00 0.89 0.85
PANC 02.03 0.03 35G>A S 0.00 0.92 0.86 0.90
HUP-T4 0.03 35G>T S 0.00 0.00 2.11 0.00
SU 86.86 0.08 35G>A S 1.30 0.00 3.73 1.40
MUT-J 0.19 WT S 0.00 0.00 0.00 0.91
PSN-1 0.20 34G>C S 2.70 5.47 1.37 4.03
SW1990 0.22 35G>A S 0.00 0.00 2.70 1.35
HPAC 0.22 35G>A S 0.00 0.00 0.00 −0.53
BXPC3 0.24 WT S 0.00 0.00 3.19 4.36
HUP-T3 0.38 34G>C S 0.00 2.06 2.20 0.00
PANC 10.05 0.42 35G>A S 0.00 0.85 0.00 −0.52
PL-45 0.56 35G>A R 0.00 0.52 0.00 0.88
HPAF-2 0.74 35G>A R 1.78 0.53 0.00 0.00
PATU 8902 0.78 35G>T R 1.27 0.82 0.00 0.89
PANC 04.03 0.82 35G>A R 0.00 0.00 −0.51 1.41
PANC 03.27 0.84 35G>T R 0.56 0.00 2.93 2.73
PATU 8988S 1.41 35G>T R −0.79 0.00 1.68 4.57
PANC 08.13 1.41 35G>A R 0.72 1.15 2.24 0.78
CAPAN-1 3.32 35G>T R 0.00 1.34 2.93 −0.53
HS-700T 3.49 WT R 0.00 2.32 0.00 0.00
PANC-1 4.42 35G>A R 0.90 0.00 2.95 −0.50
YAP-C 5.07 35G>T R 1.11 0.00 3.33 1.70
DAN-G 6.18 35G>T R 1.55 0.00 3.75 −0.62
CF-PAC 1 8.53 35G>T R 0.51 0.88 0.86 4.86
PATU 8988T 10.00 35G>T R −0.53 0.00 −0.61 4.52
P-value       0.02 0.715 0.99 1.00

Abbreviation: S/R=sensitive/resistant.

Bold=significant copy-number variations (copy-number gains (1>log2ratio>0.5), amplification (2>log2ration>1), high amplification (log2ratio>2), hemizygous deletions (−0.8<log2ratio<−1), homozygous deletions (log2ratio<−2)), KRAS mut=KRAS mutations at codon 12.